MedTrace Logo

Quality of Life Study About the Role of Turbinectomy in Rhinoseptoplasty

NCT02231216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-01-17

No results posted yet for this study

Summary

Research Question: Performing partial turbinectomy associated with rhinoseptoplasty is responsible for an increase in quality of life related to nasal obstruction when compared to no intervention in rhinoseptoplasty inferior turbinate?

* Population: patients eligible for functional rhinoseptoplasty and / or aesthetic
* Intervention: surgery, turbinectomy of inferior turbinates
* Comparison: the absence of intervention in inferior turbinates
* Primary endpoint: Quality of life related to nasal obstruction

Conditions

  • Deviated Nasal Septum
  • Nasal Septal Defect
  • Nasal Septum, Irregular

Interventions

PROCEDURE

Rhinoseptoplasty

Rhinoseptoplasty without turbinectomy procedure

PROCEDURE

Partial turbinectomy

After medial dislocation of the inferior turbinate, proceed partial resection of the inferior turbinate in all its inferior extension in range. Possible bleeding is cauterized.

PROCEDURE

Endoscopic partial turbinectomy

Endoscopy to medial dislocation of the inferior turbinate with instrument

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Bianca H Moura, MD · Hospital de Clínicas de Porto Alegre

  • Michelle Lavinsky, PhD · Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-03-31
Completion
2016-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02231216 on ClinicalTrials.gov